Alexza Pharma, Grupo Ferrer launch Adasuve in Austria - Pharmabiz. Ferrer licenses commercialisation rights for Ozenoxacin in the. Elder Pharma unveils Zalain in association with Ferrer - Yahoo India.
Ferrer CEO Jordi Ramentol Approval Rating, Owler - Polls. Elder Pharma unveils Zalain in association with Ferrer - Elder.
26 Oct 2013 Alexza Pharmaceuticals, Inc. and privately-held European R&D-based pharma company, Grupo Ferrer Internacional, S. A. have launched. Ferrer manufactures chemical, orphan drugs, partnering, hospital products. Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma Privately-held. 6 Jun 2012 Elder Pharmaceuticals in association with Spain-based drug firm Ferrer has unveiled -- Zalain -- a medicine used to treat fungal skin infections.
Ferrer to develop Lorediplon for insomnia with Ildong
1 Apr 2014 Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for Ozenoxacin one.
Grupo Ferrer Internacional SA: Company Profiles: Pharma
Ferrer Pharma Products & Contact Information, MIMS. com Philippines. Ferrer Internacional S. A. - Biotech Spain. We contribute to people's health and quality of life through the pharmaceutical, health, fine chemicals and food sectors. Our mission is to advance the wellbeing.
Ferrer licenses commercialisation rights for - PharmaVOICE. Grupo Ferrer Internacional S. A. - Company Profile - BioCentury.
Alexza Pharmaceuticals and Ferrer Provide Update on ADASUVE.
Ferrer's detailed financings. Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry analysis. Zynapse 1000 inj 250 mg_mL225a07d8-6c36-497c-bffd-a2fa01171c4f. GIF 250 mg/mL. Zynapse 500 inj 125 mg/mL: 4 mL x 5 1's. 18 Sep 2014 Grupo Ferrer Internacional, S. A. (Ferrer) is Alexza's commercial partner for ADASUVE in the European Union, Latin America and the CIS.
